Insider selling
Traded Dec 19, 2024 · filed 1 day laterNot reported under a pre-arranged trading plan
An Aim Immunotech director sold $884 of Aim Immunotech shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 2, 2024 · Filed Dec 4, 2024
An Aim Immunotech director paid $0 out of pocket for Aim Immunotech shares. 1 other person at Aim Immunotech bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$0
Shares × reported transaction price
<$25K
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.9% | −0.4% | +4.2% |
| 30 days | +21.7% | −1.9% | +23.5% |
| 90 days | −35.9% | −3.9% | −32.0% |
| 365 days | +572.8% | +13.0% | +559.8% |
Past results only. Not a forecast.
Insider selling
Traded Dec 19, 2024 · filed 1 day laterNot reported under a pre-arranged trading plan
An Aim Immunotech director sold $884 of Aim Immunotech shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Dec 18, 2024 · filed 1 day later
The CEO of Aim Immunotech paid $4.7K out of pocket for Aim Immunotech shares. 1 other person at Aim Immunotech bought some too, in the same month.
Insider buying
Traded Dec 2, 2024 · filed 2 days later
An Aim Immunotech director paid $2.4K out of pocket for Aim Immunotech shares. 1 other person at Aim Immunotech bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.